LH: Reaffirmed 2026 guidance highlights specialty testing, AI, and acquisitions as key growth drivers

Long-term guidance through 2026 was reaffirmed, with strong revenue and EPS growth targets, margin expansion, and robust free cash flow. Specialty testing, technology investments, and acquisitions are key growth drivers, while stable utilization and payer mix support financial performance. AI and o…